CORRECTION article
Front. Med.
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1677216
Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - a clinical pilot study
Provisionally accepted
Øystein Fluge1*
Ingrid Gurvin Rekeland2
Kari Sørland1Kine Alme2Kristin Risa2Ove Bruland2
Karl Johan Tronstad3
Olav Mella2- 1Haukeland University Hospital, Bergen, Norway
- 2Haukeland Universitetssjukehus, Bergen, Norway
- 3Universitetet i Bergen, Bergen, Norway
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction, page 02, column 2, first paragraph: ... However, although specific functional autoantibodies were elevated during acute COVID-19 infection (14), the number and magnitude of autoreactivities to the exoproteome were similar in individuals with or without ME/CFS (17), suggesting that the pattern of functional autoantibody responses, rather than single pathogenic autoantibodies, may be relevant.
Keywords: ME/CFS Clinical Trial, Daratumumab, Autoantibodies, Plasma cell, feasibility, Pathomechanism
Received: 31 Jul 2025; Accepted: 01 Aug 2025.
Copyright: © 2025 Fluge, Rekeland, Sørland, Alme, Risa, Bruland, Tronstad and Mella. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Øystein Fluge, Haukeland University Hospital, Bergen, Norway
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.